✦ LIBER ✦

Oral ibandronate and intravenous zoledronic acid in metastatic breast cancer patients: Comparative bone turnover marker and safety data

✍ Scribed by J.J. Body; M. Lichinitser; R.E. Coleman; B. Bergström

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial of oral ibandronate and

✍ J.-J. Body; Lichinitser; S. Tjulandin; B. Bergström 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 269 KB

408 POSTER Safety comparison of oral iba

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 125 KB

405 POSTER Phase III trial of oral iband

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Effects of intravenous zoledronic acid a

✍ Filippo Francini; Alessandra Pascucci; Gianluca Bargagli; Edoardo Francini; Raff 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 253 KB

Tolerability of oral and intravenous iba

✍ I. Schäfer; J. Seraphin; F. Schütze; A. Nusch; H. Meden; A.A. Kurth 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Intravenous and oral ibandronate provide

✍ J Body; D Tripathy; R Bell; B Bergstrom 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 334 KB